Neurogenex Co., Ltd.
Records under this name other than patents Neurogenex Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Neurogenex Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,319,001 | High throughput system for producing recombinant viruses using site-specific recombination Term ended Term ended Apr 25, 2024 · USPTO record | Term ended | Term ended Apr 25, 2024 | USPTO record |
| US 7,285,528 | Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof Lapsed on the fee record Ended Oct 23, 2015 · USPTO record | Lapsed on the fee record | Ended Oct 23, 2015 | USPTO record |